Regnum Corp RGMP
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.01
- Day Range
- $0.00–0.00
- 52-Week Range
- $0.00–0.80
- Bid/Ask
- $0.01 / $0.04
- Market Cap
- $2,295.00
- Volume/Avg
- 600 / 600
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Regnum Corp is focused on developing and commercializing therapeutics that treat rare and infectious diseases. It develops Leronlimab (PRO 140), a CCR5 antagonist to treat multi-drug resistant HIV infection.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- —
- Total Number of Employees
- 2
- Website
- https://www.regnumcorp.com
Valuation
|
Metric
|
RGMP
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
RGMP
Financial Strength
|
Metric
|
RGMP
|
|---|---|
Quick Ratio | 0.25 |
Current Ratio | 0.27 |
Interest Coverage | — |
Quick Ratio
RGMP
Profitability
|
Metric
|
RGMP
|
|---|---|
Return on Assets (Normalized) | −67.18% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | −129.63% |
Return on Assets
RGMP
Biotechnology Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Tbpwxxyjvg | Ldgn | $562.4 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Qyxbbvhgv | Kdlgtc | $103.6 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Dnqhyhl | Rgxzg | $99.5 Bil | |
MRNA
| Moderna Inc | Sgvfrgzv | Hkh | $38.8 Bil | |
ARGX
| argenx SE ADR | Pfmhrvmp | Bvs | $22.3 Bil | |
BNTX
| BioNTech SE ADR | Dztmwdc | Rvkn | $21.2 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Rtcdqjyl | Dlyyht | $18.2 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Rsnvjbmw | Vxsmvm | $17.3 Bil | |
RPRX
| Royalty Pharma PLC Class A | Ddbsksmq | Kjrnpz | $12.5 Bil | |
INCY
| Incyte Corp | Ktqztmmx | Qrnhqf | $11.6 Bil |